Central retinal vein occlusion in hypertensive patients with chronic hepatitis C treated with interferon alpha and ribavirin.
Murata
Masako
M
Department of Ophthalmology, National Hospital Organization, Matsumoto Hospital, Matsumoto, Nagano, Japan.
Tamura
Yuu
Y
Department of Ophthalmology, School of Medicine, Shinshu University, Matsumoto, Nagano, Japan.
Ohsawa
Masaya
M
Department of Ophthalmology, School of Medicine, Shinshu University, Matsumoto, Nagano, Japan.
Hirano
Takao
T
Department of Ophthalmology, School of Medicine, Shinshu University, Matsumoto, Nagano, Japan.
Matsuo
Toshihiko
T
Department of Ophthalmology, National Hospital Organization, Matsumoto Hospital, Matsumoto, Nagano, Japan.
Murata
Toshinori
T
Department of Ophthalmology, School of Medicine, Shinshu University, Matsumoto, Nagano, Japan. murata@shinshu-u.ac.jp.
D000998:Antiviral Agents / Q000009:adverse effects*; D005260:Female; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000150:complications*; D016898:Interferon-alpha / Q000009:adverse effects*; D008875:Middle Aged; D012170:Retinal Vein Occlusion / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D012254:Ribavirin / Q000009:adverse effects*; D014786:Vision Disorders / Q000209:etiology
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin